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The prostate undergoes branching morphogenesis dependent on paracrine interactions between the prostatic epithelium and
the urogenital mesenchyme. To identify cell-surface molecules that function in this process, monoclonal antibodies raised
against epithelial cell-surface antigens were screened for antigen expression in the developing prostate and for their ability
to alter development of prostates grown in serum-free organ culture. One antibody defined a unique expression pattern in
the developing prostate and inhibited growth and ductal branching of cultured prostates by inhibiting epithelial cell
proliferation. Expression cloning showed that this antibody binds fucosyltransferase1, an a-(1,2)-fucosyltransferase that
synthesizes H-type structures on the complex carbohydrate modifications of some proteins and lipids. The lectin UEA I that
binds H-type 2 carbohydrates also inhibited development of cultured prostates. These data demonstrate a previously
unrecognized role for fucosyltransferase1 and H-type carbohydrates in controlling the spatial distribution of epithelial cell
proliferation during prostatic branching morphogenesis. We also show that fucosyltransferase1 is expressed by epithelial
cells derived from benign prostatic hyperplasia or prostate cancer; thus, fucosyltransferase1 may also contribute to
pathological prostatic growth. These data further suggest that rare individuals who lack fucosyltransferase1 (Bombay
phenotype) should be investigated for altered reproductive function and/or altered susceptibility to benign prostatic
hyperplasia and prostate cancer. © 2001 Academic Press
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bINTRODUCTION
The prostate is a branched ductal-acinar gland that pro-
duces a major fraction of seminal fluid. Ductal branching
morphogenesis of the prostate resembles that of other
glandular organs, such as the mammary gland, salivary
gland, and pancreas; however, it differs from these glands in
that prostatic development occurs only in males and de-
pends on the presence of androgens (Cunha et al., 1987). In
recent years, considerable progress has been made toward
identifying genes required for prostatic development. These
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All rights of reproduction in any form reserved.nclude several transcription factors including the androgen
eceptor (Cunha and Lung, 1978; Cunha and Young, 1991;
onjacour and Cunha, 1993; He et al., 1991) and three
omeodomain-containing transcription factors Hoxa13,
oxd13 (Oefelein et al., 1996; Podlasek et al., 1999b, 1997;
arot et al., 1997), and Nkx3.1 (Bhatia-Gaur et al., 1999;
ieberich et al., 1996; Sciavolino et al., 1997). Several
rowth factors have also been implicated in prostatic devel-
pment. These include two members of the fibroblast
rowth factor (FGF) family, FGF7 and FGF10 (Sugimura et
l., 1996; Thomson and Cunha, 1999; Thomson et al.,
997), as well as insulin-like growth factor 1 (Ruan et al.,
999) and sonic hedgehog (Podlasek et al., 1999a).
In spite of this progress, the molecular mechanisms
ehind much of prostatic development have not yet been95
e
g
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96 Marker et al.uncovered. Tissue recombination and grafting experiments
have clearly demonstrated that multiple paracrine signaling
events between the developing prostatic mesenchyme and
FIG. 1. Expression of Ag 2103 in the reproductive tract of the mal
of the neonatal ventral prostate (A), dorsolateral prostate (B), and a
seminal vesicle (D), ductus deferens (E), epididymis (F), or testis (G)
was observed on the apical side of the epithelium and in prostatic s
as a negative control is also shown (I). Costaining neonatal ventra
with visualization by confocal fluorescence microscopy revealed si
of Ag 2103 on the cell surface of the prostatic epithelium. Although
of epithelial cells does not express the antigen (arrows in A and B)Copyright © 2001 by Academic Press. All rightpithelium are required both for normal branching morpho-
enesis and for the differentiation of specialized stromal
nd epithelial cell types (Cunha et al., 1987). Thus, mol-
. Ag 2103 expression (brown stain) was observed in the epithelium
ior prostate (C). Ag 2103 expression was not detected in neonatal
dult prostate where the secretory epithelium is polarized, staining
ions (H). A neonatal ventral prostate stained with total mouse IgM
tates for Ag 2103 (J) and the epidermal growth factor receptor (K)
cant colocalization (yellow in L), thus demonstrating the presence
ssion was detected in the developing prostatic epithelium, a subset
agnification scale for A–I is shown in C.e rat
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97FUT1 Mediates Prostatic MorphogenesisFIG. 2. Three-dimensional reconstruction of Ag 2103 expression in the neonatal rat ventral prostate. Serial 10-mm sections were made through
a neonatal rat ventral prostate. Alternate sections were stained with a pan-cytokeratin antibody that stains all prostatic epithelial cells or mAb
2103. Examples of adjacent sections stained with the pan-cytokeratin antibody (A) and mAb 2103 (C) are shown. After three-dimensional
reconstruction of the expression patterns, the pan-cytokeratin antibody (B) and mAb 2103 (D) revealed a branched three-dimensional structure.
However, immunostaining with mAb 2103 revealed a less complex pattern than the one revealed by immunostaining with the pan-cytokeratin
antibody [see the superimposition of the two patterns (E)]. A magnification scale for A and C is shown in C.
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98 Marker et al.ecules at the cell surface and in the extracellular microen-
vironment are crucial for prostatic development. A class of
molecules that has not been studied in the developing
prostate is the group of enzymes that synthesize the com-
plex carbohydrate modifications present on some proteins
and lipids at the cell surface and in the extracellular
microenvironment. Such modifications of proteins and lip-
ids are a common feature of many cell types in metazoans.
The sugar composition and overall structure of these com-
plex carbohydrates is determined by the composite enzy-
matic activity of proteins in the secretory pathway and at
the cell surface that catalyze the addition or modification of
carbohydrate groups on acceptor molecules.
In many cases, carbohydrate-modifying enzymes are ex-
pressed in a spatially and temporally restricted manner. For
example, in the developing chick embryo, the temporal and
spatial distribution of multiple classes of glycosyltransferases,
including fucosyltransferases, has been correlated with devel-
opmental events (Shur, 1977). Complex carbohydrates at the
cell surface are also clearly important for development. For
example, in N-acetylglucosaminyltransferase I-deficient mice,
hich die at midgestation, the absence of complex N-linked
arbohydrate modifications is associated with a retarded
rowth as well as neural, vascular, and left–right asymmetry
efects (Ioffe and Stanley, 1994; Metzler et al., 1994). A further
emonstration of the important role of carbohydrate-
odifying enzymes in development is the recent demonstra-
ion that Fringe molecules act as glycosyltransferases to
odulate signaling through Notch receptors during develop-
ent in both Drosophila and vertebrates (Bruckner et al.,
000; Moloney et al., 2000).
We conducted a monoclonal antibody screen to identify
ell-surface molecules important for prostatic develop-
ent. Here, we report our findings for one monoclonal
ntibody, 2103 (mAb 2103), that revealed an interesting and
nique staining pattern within the developing prostate and
nhibited prostatic ductal branching morphogenesis by re-
ucing epithelial cell proliferation. Expression cloning with
Ab 2103 identified the fucosyltransferase1 (FUT1) gene,
hus implicating a-(1,2)-fucosyltransferase and H-type car-
bohydrate structures as important mediators of prostatic
development. This finding was further supported by the
observation that lectin UEA I that binds H-type 2 carbohy-
drate structures also inhibited growth and ductal branching
morphogenesis of cultured ventral prostates. We also show
that the human FUT1 gene is expressed by prostatic epithe-
ial cells derived both from patients with benign prostatic
yperplasia and from patients with prostate cancer.
MATERIALS AND METHODS
Immunohistochemistry and TUNEL Assay
Immunohistochemistry was performed either on formalin-fixed/
paraffin-embedded tissues or on unfixed frozen tissue embedded in
OCT (Tissue-Tek, Torrance, CA). For formalin-fixed/paraffin-
embedded tissues (see data in Figs. 1A–1I, 3, 4, and 6), 6-mm
ections were cut, deparaffinized in histoclear (National Diagnos-Copyright © 2001 by Academic Press. All rightics, Atlanta, GA), and rehydrated through decreasing grades of
lcohol into PBS. Antigen retrieval was performed by using
ntigen-unmasking solution (Vector Laboratories, Burlingame,
A). For tissues frozen in OCT (see data in Figs. 1J–1L and 2),
0-mm sections were cut, fixed in acetone at 220°C for 2 min, air
dried, and rehydrated in PBS. From this point, both formalin-fixed/
paraffin-embedded and tissue frozen in OCT were treated identi-
cally. Prior to staining, sections were treated for 10 min with 3%
H2O2 and blocked with blocking solution (Immunovision, Spring-
ale, AR). mAb 2103 was used over a dilution range of 1:100 (20
mg/ml) to 1:500 (4 mg/ml) in blocking solution; the pan-cytokeratin
antibody (Dako Corp., Carpinteria, CA) was diluted 1:200 in
blocking solution; the Ki67 antibody (Vector Laboratories) was
diluted 1:100 in blocking solution; the epidermal growth factor
receptor antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was
diluted 1:200 in blocking solution. Secondary antibodies were
anti-mouse biotin-conjugated, anti-rabbit biotin-conjugated, anti-
mouse FITC-conjugated, and anti-rabbit TRITC-conjugated (Sigma,
St. Louis, MO) used at dilution 1:200 in PBS containing 1% sheep
serum. For biotin-conjugated secondary antibodies, immunostain
was developed by using the Vectastain Peroxidase System (Vector
Laboratories), and sections were counterstained with hematoxylin.
For FITC- and TRITC-conjugated secondary antibodies, staining
was visualized directly with confocal fluorescence microscopy.
Apoptosis was visualized with the TUNEL assay (Gavrieli et al.,
1992) using an ApopTag kit (Intergen, Purchase, NY).
Three-Dimensional Reconstruction
A complete set of serial 10-mm sections was prepared from a
eonatal rat ventral prostate. Alternate sections were stained with
he pan-cytokeratin antibody or mAb 2103. Sections were counter-
tained with hematoxylin, mounted, and imaged with a CCD
amera. Images were imported into Photoshop (Adobe Systems,
an Jose, CA) and aligned based on histological landmarks brought
ut by the hematoxylin counterstain. The expression domains for
ytokeratin and Ag 2103 were traced in Photoshop, and the aligned
races were exported to NIH Image software. NIH Image software
as used to assemble the stack of aligned traces into three-
imensional projections of the expression patterns.
Organ Culture
Ventral prostates were dissected from neonatal Sprague–Dawley
rats into basal culture medium at 4°C. Organs were cultured on
Millicell-CM membranes (Millipore, Bedford, MA) floating on the
surface of culture medium in a 5% CO2, 37°C incubator. Culture
medium was DME 50% H-16/50% F-12 medium containing NEAA
supplements, 1.4 g/liter glucose, 0.37 g/liter L-glutamine, 42 mg/
iter linoleic acid, 1.2 g/liter NaHCO3, 10 mg/ml insulin, 10 mg/ml
ransferrin, and 1 3 1029 M testosterone. Antibodies were used at
00 mg/ml. Lectins UEA I, PNA, and DBA (Sigma) were used at 10
mg/ml. Culture medium was changed every other day during the
culture period. Statistical tests were ANOVA followed by least
significant difference analysis using Statistica software (Statsoft,
Tulsa, OK).
Expression Cloning
Messenger RNA was isolated directly from cultured BUD cells,
and a BUD cDNA library was constructed as described previously
(Stephan et al., 1999a,b). Screening of the BUD cell library was
carried out by using a modified version of a technique previouslys of reproduction in any form reserved.
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99FUT1 Mediates Prostatic Morphogenesisdescribed (Seed and Aruffo, 1987). Briefly, the cDNA library was
transfected into COS cells by electroporation (Neumann et al.,
1982). After 2 days of culture, transfected COS cells were resus-
pended, then incubated with a pool of anti-BUD cell antibodies (2
mg/ml each) (Stephan et al., 1999a,b) and replated onto dishes
coated with affinity-purified rabbit anti-mouse IgG and IgM. A Hirt
supernatant was prepared from adherent cells and used to trans-
form competent Escherichia coli. After amplification, bacterial
colonies were harvested, then plasmid cDNA was isolated using
the alkaline miniprep method (Birnboim and Doly, 1979) and
transfected into COS cells to perform a new round of immuno-
selection. After four rounds of panning with the pooled antibodies
and five additional rounds with mAb 2103, the cDNA clone 2103
was purified. ABI Dye-terminator chemistry (PE Applied Biosys-
tems, Foster City, CA) was used to sequence the clone 2103 with a
primer walking strategy (Sanger et al., 1977). The sequences were
collected with an ABI377 instrument (PE Applied Biosystems). The
sequences generated by the different walking primers for both
DNA strands were edited and assembled in the Sequencher (Gene
Codes Corp., Ann Arbor, MI). All sequence analyses were per-
formed by using an in-house sequence analysis program (Genen-
tech, Inc., South San Francisco, CA). The program ALIGN (Dayhoff
et al., 1983) was used to analyze the relationship between the clone
2103, hFUT1, hFUT2. To confirm that the rat FUT1 protein is the
ntigen recognized by mAb 2103, the full-length FUT1 cDNA was
ransfected into COS cells. The COS cells (mock cDNA or FUT1
DNA transfected) were detached from tissue culture flasks in the
resence of nonenzymatic cell dissociation solution (Sigma), cen-
rifuged, and resuspended in PBS/1% BSA. The cells were counted
nd 106 cells were incubated on ice in 1 ml of PBS/1% BSA
ontaining 4 mg of purified mAb 2103. After 1 h of incubation, cells
ere washed and incubated with Cy3-conjugated affinity-purified
oat anti-mouse IgM for 30 min before being washed and analyzed
ith a FACScan cell sorter (Becton Dickinson, Mountain View,
A). Immunostaining was also observed by using fluorescence
icroscopy after conterstaining with Hoechst solution (Molecular
robes, Eugene, OR).
Real-Time Quantitative RT-PCR Analyses
After isolation, total RNAs were DNAse I-treated and RNA
concentrations were determined by using the RiboGreen RNA
Quantification kit (Molecular Probes). Real-time quantitative RT-
PCR analyses for FUT1 were performed by using an ABI PRISM
7700 Sequence Detection System (PE Applied Biosystems) accord-
ing to the protocols previously described (Gelmini et al., 1997;
ibson et al., 1996; Heid et al., 1996). The sequences of the
ligonucleotides used as primers and probes for the real-time
uantitative RT-PCR analyses are as follows: rat FUT1, forward
rimer 59-AAG ACG CAC AGC GCC TGT-39, reverse primer
9-ACA TAG GTA CGA GGA CGG ATG C-39, probe 59-AGT
GG CTC CGG ATA GGC CCT G-39; human FUT1, forward
rimer 59-TGG CCG GTT TGG TAA TCA G -39, reverse primer
9-CGT TGA GCT GGG CCA GAG -39, probe 59-TGG GAC AGT
TG CCA CGC TGC TG -39. Glyceraldehyde-3-phosphate-
eshydrogenase (GAPDH) and cytokeratin19 were chosen as inter-
nal standard to control for variability in amplification due to
differences in starting mRNA concentration. The relative expres-
sion level of FUT1 gene was computed with respect to the
xpression level of the internal standard.Copyright © 2001 by Academic Press. All rightRESULTS
Previous work has raised and characterized a panel of
monoclonal antibodies against rat embryonic pancreatic
ductal epithelial cell lines (BUD and RED; Stephan et al.,
1999b). The developing prostate and pancreas share many
common features. These include branching morphogenesis
of an endodermally derived epithelium and a dependence on
paracrine interactions with the surrounding mesenchyme
(Golosow and Grobstein, 1962). Reasoning that common
molecular pathways may function in the development of
both organs, we screened the panel of pancreatic monoclo-
nal antibodies for antigen expression in prostates undergo-
ing branching morphogenesis as well as for their ability to
perturb branching morphogenesis of prostates grown in
serum-free organ culture. mAb 2103 from the BUD/RED
monoclonal antibody panel revealed a novel expression
pattern in the developing prostate and inhibited develop-
ment of rat ventral prostates grown in serum-free organ
culture.
Expression of the 2103 Antigen
Expression of the 2103 antigen (Ag 2103) was observed in
each prostatic lobe in neonatal rats, a developmental stage
that includes active branching morphogenesis (Figs. 1A–
1C). Expression was not detected in other male reproduc-
tive structures at this developmental stage (Figs. 1D–1G,
and data not shown). In the adult prostate, where the
prostatic epithelium is differentiated into basal cells and
polarized luminal cells, Ag 2103 was observed on the apical
side of luminal cells and in the prostatic secretions (Fig.
1H). mAb 2103 was raised against cell-surface epitopes on
pancreatic epithelial cells. To confirm the presence of Ag
2103 on the surface of prostatic epithelial cells, neonatal rat
ventral prostates were costained with mAb 2103 and an
antibody against a known cell-surface protein, the epider-
mal growth factor receptor (EGFR). Staining was visualized
by confocal microscopy (Figs. 1J–1L). Substantial colocal-
ization of Ag 2103 with EGFR (yellow in Fig. 1L) confirms
the partial presence of Ag 2103 on the surface of prostatic
epithelial cells. Punctate cytoplasmic staining was also
observed and may reflect localization to compartments in
the secretory pathway.
Although extensive expression of Ag 2103 was detected
in the developing prostatic epithelium, a significant frac-
tion of epithelial cells was not immunostained by mAb
2103 (arrows in Figs. 1A and 1B). To further characterize the
expression pattern of Ag 2103, we undertook three-
dimensional reconstruction of the expression pattern in the
neonatal rat ventral prostate, including a direct comparison
to the pattern revealed by a pan-cytokeratin antibody that
stains all prostatic epithelial cells. Serial sections through a
neonatal rat ventral prostate were alternately stained with
the pan-cytokeratin antibody or mAb 2103 (examples of
adjacent sections shown in Figs. 2A and 2C). Three-
dimensional reconstructions of the expression patterns
were made by using NIH Image software. The pan-s of reproduction in any form reserved.
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100 Marker et al.cytokeratin antibody and mAb 2103 both revealed a
branched three-dimensional structure (Figs. 2B and 2D).
However, the three-dimensional structure revealed by mAb
2103 was less complex than the one revealed by the
pan-cytokeratin antibody, as was evident in the superimpo-
sition of the two patterns (Fig. 2E). Expression of Ag 2103
was observed in both the most proximal and in very distal
epithelial ducts, but was not observed in the urethral
epithelium. Expression was also absent from a subset of
both proximal and distal prostatic epithelium. No similar
pattern has been previously reported for other genes during
prostatic branching morphogenesis. Thus, this antigen pro-
vides a new marker for a unique subset of cells within the
developing prostatic epithelium.
FIG. 3. Inhibition of testosterone-stimulated prostatic growth and
underwent extensive growth and branching morphogenesis when c
vs. B, 5 days in culture). The addition of mAb 2103 (100 mg/ml) to
ranching morphogenesis during the 5-day culture period (C). The a
or organs grown in testosterone-containing serum-free medium (n 5
edium with testosterone and mAb 2140 (n 5 6), and medium w
ndicate the standard error for each data point. A monoclonal antib
ranching morphogenesis and luminal cells after epithelial differe
ultured organs. Staining after 3 days of culture (E, G) shows that m
ultures. Staining at the end of the culture period (F, H) shows that b
nd appropriately express cytokeratin 8 in luminal epithelial cellsCopyright © 2001 by Academic Press. All rightInhibition of Prostatic Branching Morphogenesis
by mAb 2103
The neonatal rat ventral prostate undergoes extensive
growth and branching morphogenesis when cultured in
testosterone-containing, serum-free medium (Lipschutz et
al., 1997). In the presence of testosterone and mAb 2103,
testosterone-stimulated growth and branching morphogen-
esis were significantly reduced relative to either testoster-
one alone or testosterone with total mouse IgM as controls
(Figs. 3B and 3C). During the culture period, organs were
imaged daily, and the area of each organ was measured.
mAb 2103 reduced the normalized organ growth of treated
prostates 60.4% relative to total IgM-treated controls (Fig.
ching morphogenesis by mAb 2103. Neonatal rat ventral prostates
ed in testosterone-containing serum-free medium (A, culture start
estosterone-containing basal medium greatly reduced growth and
e increase in area (normalized for each organ to its own initial size)
, medium with testosterone and total mouse IgM (n 5 7) as control,
estosterone and mAb 2103 (n 5 9) are shown (D). The error bars
gainst cytokeratin 8 which stains all epithelial cells during ductal
ion was used to stain control (E, F) and mAb 2103-treated (G, H)
103-treated organs grow with thicker epithelial ducts than control
Ab 2103-treated and control cultures undergo ductal canalization
agnification scale for E–H is shown in H.bran
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101FUT1 Mediates Prostatic Morphogenesis3D). This difference was highly significant (ANOVA test
with least significant difference post hoc analysis, P ,
0.0001). Among the other antibodies from the BUD/RED
panel that also bound prostatic cell-surface epitopes, several
had no effect on cultured rat ventral prostates, for example,
mAb 2140 (Fig. 3D). These results suggest that the inhibi-
tory activity of mAb 2103 does not simply result from
binding the prostatic epithelial cell-surface. In addition to
inhibiting overall growth of cultured organs, mAb 2103
affected branching morphogenesis. This is evident both
from the overall appearance and from the histology of mAb
2103-treated organs relative to controls. Ventral prostates
treated with mAb 2103 had a ductal network composed of
thicker epithelial cords, which were less branched than
controls (Figs. 3B, 3C, 3E, and 3G). Although growth and
branching of ventral prostates were greatly reduced by mAb
2103, it did not affect other major differentiation events
that occur during the culture period, and no evidence of
cytotoxic effects was observed in analysis of mAb 2103-
treated organs. Histological analysis and immunohisto-
chemistry with differentiation markers showed that mAb
2103-treated organs initiated ductal canalization and under-
went both epithelial and stromal differentiation in a man-
ner indistinguishable from controls (Figs. 3F and 3H, and
data not shown). The effects of mAb 2103 on cultured
ventral prostates suggest that Ag 2103 is an important
mediator of prostatic growth and branching behavior during
development.
FIG. 4. Apoptosis and proliferation in mAb 2103-treated ventral pr
medium, control (A and B) and mAb 2103-treated organs (D and E)
Ki67 staining (B and E). Apoptotic cells (green label) were rare fo
extensive in control than mAb 2103-treated organs. The Ki67-labeli
The averages for six organs in each group are shown (C). The errorCopyright © 2001 by Academic Press. All rightMechanism of mAb 2103 Growth Inhibition during
Prostatic Development
mAb 2103 reduced the normalized organ growth (as
measured by area increase) of treated prostates 60.4%
relative to controls. To understand the mechanism of this
inhibition, cultured prostates were examined for apoptosis
by using the TUNEL technique (Gavrieli et al., 1992) and
for cell proliferation by staining with a monoclonal anti-
body against the Ki67 nuclear antigen that has previously
been used to measure proliferation in prostatic cells (Gallee
et al., 1989). Apoptosis levels were low in the growing ducts
of both control and mAb 2103-treated organs (Figs. 4A and
4D). Proliferation as measured by Ki67 staining was more
extensive in the epithelium of control cultures relative to
mAb 2103-treated cultures (Figs. 4B and 4E). Quantification
of the epithelial Ki67-labeling index in control and treated
cultures confirmed a significantly lower labeling index
(ANOVA test with least significant difference post hoc
analysis, P , 0.01) in mAb 2103-treated cultures (Fig. 4C).
No difference in labeling index was observed between
control and treated cultures in the developing mesenchyme
(Fig. 4C). At the early developmental stage used for the
prostatic organ cultures, proliferation occurs at a uniform
rate in both proximal and distal epithelial ductal cords. The
decrease in proliferation caused by mAb 2103 treatment
was observed in both proximal and distal regions of the
prostatic epithelium.
es. After 3 days in culture with testosterone-containing serum-free
analyzed for apoptosis by TUNEL (A and D) and proliferation by
h control and mAb 2103-treated organs. Ki67 staining was more
dex in the epithelium (epi) and mesenchyme (mes) was determined.
indicate the standard error for each data point.ostat
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102 Marker et al.Expression Cloning of the 2103 Antigen
A cDNA library constructed from the BUD cell line was
expressed in COS cells. Panning was used to select for cells
expressing cDNAs encoding the antigens recognized by the
BUD/RED monoclonal antibody panel. The initial four
rounds of selection used pooled monoclonal antibodies.
After five additional rounds with mAb 2103 alone, a single
cDNA was isolated and sequenced. The resulting 1621-bp
cDNA sequence was 98.4% identical to the 39-end of the
published rat fucosyltransferase1 [FUT1, also known as
FUTA (Piau et al., 1994)] mRNA (Fig. 5A). All sequence
differences between the Ag 2103 clone and the published
FUT1 mRNA sequence were in the 39-untranslated portion
of the cDNA. Based on sequence comparisons, this rat gene
is the ortholog of the human fucosyltransferase1 gene
[originally called the H gene (Larsen et al., 1990)] that
ncodes an a-(1,2)-fucosyltransferase enzyme that synthe-
izes H-type structures on the complex carbohydrate modi-
cations of some proteins and lipids. In addition, the
rotein encoded by this rat gene has been shown to have
a-(1,2)-fucosyltransferase enzymatic activity (Soejima et al.,
1999). To confirm that mAb 2103 recognizes the rat FUT1
protein, a full-length FUT1 cDNA was PCR cloned from the
UD cell cDNA library and transfected into COS cells.
ransfected cells were analyzed for mAb 2103 binding by
ACS and immunocytochemistry (Figs. 5B1 and 5B2). As
xpected, the COS cells transfected with the full-length
UT1 cDNA were positive for Ag 2103 by both FACS and
mmunocytochemistry. No binding was observed with
OS cells transfected with a control cDNA. These data
uggest that mAb 2103 binds an epitope in the FUT1
rotein.
Staining Pattern and Inhibitory Activity of Lectin
UEA I
The lectin UEA I binds to the H antigen that results from
the activity of a-(1,2)-fucosyltransferase on a type 2 carbo-
hydrate base structure. The staining pattern of the antigen
recognized by mAb 2103 was compared to the staining
pattern for the UEA I lectin in serial sections of rat ventral
prostates (Figs. 6A and 6B). The staining patterns were very
similar for both reagents with some epithelial ducts posi-
tive for both and others negative for both. For positive
ducts, the lectin UEA I typically reacted with all epithelial
cells, while mAb 2103 typically reacted with the core
portion of the duct with some unstained peripheral epithe-
lial cells (arrows in Figs. 6A and 6B). The overall similar
staining patterns for mAb 2103 and lectin UEA I support
our identification of Ag 2103 as a-(1,2)-fucosyltransferase.
Several mechanisms could account for the presence of H
antigens on cells adjacent to FUT1-expressing cells. It may
reflect dynamic changes in FUT1 expression during pros-
tatic development combined with different rates of meta-
bolic turnover for FUT1 relative to the fucosylated products
resulting from its activity. It may reflect the synthesis of H
epitopes on adjacent cells by FUT1 that our FACS data (Fig.Copyright © 2001 by Academic Press. All right5B) indicates is present on the cell surface. Finally, it may
reflect the synthesis of H epitopes on diffusible factors that
originate from FUT1 expressing cells.
Lectin UEA I also reduced the testosterone-stimulated
growth of ventral prostates in serum-free organ culture
37.6% relative to control lectins (Figs. 6C–6F). This differ-
ence was highly significant (ANOVA test with least signifi-
cant difference post hoc analysis, P , 0.0001). Control
lectins were DBA (control lectin 1) and PNA (control lectin
2). PNA has previously been reported to bind prostatic
epithelial cells (Abel et al., 1990). Growth in the presence of
these control lectins was not significantly different from
growth in the presence of testosterone alone.
In addition to decreasing organ growth, lectin UEA I
affected prostatic branching morphogenesis in a manner
qualitatively similar to the effect of mAb 2103. Both re-
agents reduced ductal branching and resulted in epithelial
cords that were thicker relative to controls as observed by
gross appearance and histology (Figs. 3C and 6F, and data
not shown). These data support the idea that the carbohy-
drate structures produced by the activity of a-(1,2)-
ucosyltransferase are important for regulating prostatic
rowth and ductal branching during prostatic development.
FUT1 Expression Is Not Androgen-Regulated
during Prostate Development
Since it has been reported that FUT1 transcription is
under steroid hormone control in the uterus (Sidhu and
Kimber, 1999), we investigated the possibility that FUT1
transcription might be under androgen control in the devel-
oping prostate. Prostates were cultured in the presence of
physiologic levels of testosterone (1029 M) or in the pres-
nce of 100-fold excess cyproterone acetate, an anti-
ndrogen. FUT1 mRNA was quantified at daily intervals by
eal-time quantitative RT-PCR (Taqman). In the presence of
oth testosterone and cyproterone acetate, a time-
ependent increase of FUT1 mRNA expression was ob-
erved during the initial days of the culture period with a
light decline (relative to maximum) seen by 6 days in
ulture (Fig. 7A). The overall similarity of expression pro-
les and relative expression levels of FUT1 in organs
reated with testosterone and cyproterone acetate suggests
hat androgens do not directly regulate FUT1 mRNA levels
n the developing prostate.
FUT1 mRNA Expression in Human and Rat
Prostate Cell Lines and Primary Isolates
In order to investigate the potential role of FUT1 during
pathological prostatic growth, the expression of FUT1
mRNA was examined in two cell lines derived from normal
adult rat prostate (NRP152 that is nontumorigenic,
NRP154 that is tumorigenic), one cell line derived from a
rat prostate tumor (Dunning Epithelium 5 DE), four pri-
ary isolates of human prostatic epithelium from patients
ith benign prostatic hyperplasia (hPRE1, hPRE2, hPRE4,
nd hPRE5), one human cell line derived from benigns of reproduction in any form reserved.
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103FUT1 Mediates Prostatic Morphogenesisprostatic hyperplasia (BPH1), and four human cell lines
derived from metastatic prostate tumors (DU145, LNCAP,
ND1, and PC3). All of the cells examined expressed FUT1
mRNA (Figs. 7B and 7C). Among the rat cell lines, the
highest expression was seen in the nontumorigenic
NRP152 line, while the lowest expression was observed in
the tumorigenic DE cell line. Among the human cells, the
three with highest expression were derived from benign
prostatic hyperplasia, and the sample with the lowest
expression was tumor derived.
DISCUSSION
a-(1,2)-Fucosyltransferase enzymes synthesize the H an-
tigenic determinant (Fuc a1–2Gal-R) by catalyzing the
ransfer of L-fucose from GDP-fucose to one of several
arbohydrate precursor structures containing a terminal
b-D-galactose residue. The resulting carbohydrate struc-
ures are the precursors for the A, B, Lewis b (Leb), and
ewis Y (Ley) blood group determinants (Clausen and Ha-
omori, 1989). Through binding studies with reagents di-
ected against the H antigen and its derivatives, it is known
hat these carbohydrate structures are present in multiple
issues in adults and during development (Fenderson et al.,
986; Szulman, 1962, 1964). Changes in these antigens have
lso been associated with cancer progression, including the
bservation that high expression of H/Ley correlates with
oor survival for some cancers (Hakomori, 1996). In the
rostate, the H and Ley antigens are expressed in a large
fraction of metastatic cancers, although expression is not
prognostic for survival in these high-grade cancers (Jor-
gensen et al., 1995). The status and prognostic value of
these antigens in lower-grade prostatic cancer is not known.
These surveys of antigen distribution suggest potential
roles for a-(1,2)-fucosyltransferase enzymes in the develop-
ent, homeostasis, and pathology of several tissues.
In rodents and humans, at least two genes encode a-(1,2)-
ucosyltransferase, fucosyltransferase1 and fucosyltrans-
ferase2 [FUT1 and FUT2—these genes were originally
named H and Secretor—in humans (Kelly et al., 1995;
Larsen et al., 1990) and FUTA and FUTB in rats (Piau et al.,
1994)]. Beginning in preimplantation embryos, the expres-
sion of FUT1 is developmentally regulated (Liu et al., 1999).
FUT1 expression is also found in a subset of adult organs
(Domino et al., 1997). Relatively little is known about the
expression of FUT1 in organogenesis and in early postnatal
stages. Our studies focused on neonatal development of the
male reproductive tract. During this period, we found that
the FUT1 protein was highly expressed in the prostate but
not in other male reproductive structures.
The developmental expression of FUT1 in the prostate
coincides with branching morphogenesis and defines a
novel three-dimensional pattern such that FUT1 provides a
marker for a subset of cells not previously known to possess
unique characteristics. During branching morphogenesis,
epithelial ducts grow invasively into the urogenital mesen-
chyme and form branches at regular intervals. The variousCopyright © 2001 by Academic Press. All rightateral branches must also cease this process appropriately
o establish the final branched pattern stereotypical for each
rostatic lobe (Sugimura et al., 1986). This implies that
ifferent parts of the developing ductal network will ac-
uire distinct molecular properties as some lateral ducts
ease morphogenesis, while others continue to develop.
andidate molecules that regulate this process have not yet
een identified. It is tempting to speculate that the unique
taining pattern of mAb 2103, which includes both proxi-
al and distal epithelial ducts but only a subset of lateral
ranches, may identify early segregation of epithelial cell
opulations important for controlling the final branched
attern of the prostate.
FUT1 provides more than a new marker for branching
vents in the developing prostate. mAb 2103 binds FUT1
nd inhibits the overall growth and branching morphogen-
sis of prostates grown in serum-free organ culture by
imiting epithelial cell proliferation. A similar inhibition of
rgan growth is observed in presence of lectin UEA I that
inds carbohydrate epitopes synthesized by FUT1. Since
Ab 2103 and lectin UEA I do not inhibit lumen formation
r the differentiation of specialized epithelial and stromal
ell types during the culture period, our data are consistent
ith a specific role for FUT1 and H-type carbohydrate
pitopes in regulating epithelial proliferation during
ranching morphogenesis. Furthermore, our data show that
UT1 has a developmentally regulated and spatially re-
tricted expression pattern in the prostate. Thus, the
roliferation-modulating activity of this enzyme can con-
ribute to controlling the spatial distribution of epithelial
roliferation during prostatic branching morphogenesis.
It is interesting that mAb 2103 can affect organ develop-
ent even though the synthesis of H-type carbohydrate
tructures occurs primarily in the secretory pathway. FACS
nalysis of cells expressing a full-length FUT1 cDNA clone
indicates that FUT1 protein is present on the cell surface.
This is in agreement with previously published studies
reporting a significant fraction of a-(1,2)-fucosyltransferase
activity at the plasma membrane (Hartel-Schenk et al.,
1991). Presumably, the effect of mAb 2103 on prostatic
development is the result of binding to cell-surface a-(1,2)-
fucosyltransferase. Although previous work does not pro-
vide evidence that a-(1,2)-fucosyltransferase has a cell-
surface specific function, another glycosyltransferase,
b-1,4-galactosyltransferase, which is present both in the
secretory pathway and on the cell surface, has been shown
to function directly as an adhesion molecule (Evans et al.,
993; Lu and Shur, 1997). The inhibitory activity of mAb
103 may reflect interference with a similar function of
a-(1,2)-fucosyltransferase. It is also possible that FUT1
functions enzymatically at the cell surface. We observed
lectin UEA I staining in cells adjacent to but not stained by
mAb 2103. This could result from the synthesis of H
epitopes on adjacent cells by cell-surface FUT1.
As epithelial ducts cease morphogenesis and undergo
secretory cytodifferentiation, FUT1 becomes localized to
the apical side of the polarized luminal epithelial cells ands of reproduction in any form reserved.
FIG. 5. Identification of Ag 2103. Expression cloning isolated a cDNA (1621 bp) coding for Ag 2103 that is shown aligned with the
complete sequence of rat FUT1 (A). The Ag 2103 cDNA clone was 98.4% identical to the 39-end of the published rat fucosyltransferase1
[FUT1, also known as FUTA (Piau et al., 1994)] mRNA (A). All sequence differences between the Ag 2103 clone and the published FUT1
mRNA sequence were in the 39-untranslated portion of the cDNA. To confirm that mAb 2103 recognizes the rat FUT1 protein, a full-length
FUT1 cDNA was PCR cloned from the BUD cell cDNA library and transfected into COS cells. (B1) The COS cells transfected with the
full-length FUT1 cDNA (red) or a mock cDNA (black) were analyzed by FACS for the binding of mAb 2103. (B2) Immunofluorescence
staining with mAb 2103 (red) also confirms the presence of Ag 2103 on the FUT1-transfected COS cells (purple, nuclear counter stain).
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105FUT1 Mediates Prostatic Morphogenesisto prostatic secretions. This may reflect a change in func-
tion for FUT1 in the prostate from an enzyme that synthe-
sizes carbohydrate epitopes important for developmental
processes to one that serves in the adult to modify proteins
in prostatic secretions. It should be noted that the prostatic
epithelium loses its polarity during the progression of
cancer (Gleason, 1977). We show that FUT1 is still ex-
ressed by several prostate cancer cell lines. Thus, in
rostate cancer, a-(1,2)-fucosyltransferase is available to
synthesize H-type carbohydrate epitopes in an unpolarized
epithelium more typical of its developmental role. A previ-
ous investigation of H and Ley antigens in metastatic
rostate cancer found that these antigens are present in
any cancers. However, these antigens are not prognostic
or survival in these high-grade cancers (Jorgensen et al.,
995). It would be interesting to extend these studies to
nclude earlier stages of prostate cancer since premetastatic
denocarcinomas represent a caricature of prostatic ductal
ranching morphogenesis.
Our data implicate FUT1 and H-type complex carbohy-
rate modifications as crucial mediators of important
vents during prostatic branching morphogenesis. Expres-
ion in normal, benign prostatic hyperplasia, and tumor-
erived prostatic epithelial cells further raises the possibil-
ty that FUT1 may be important in adults for normal
rostate function as well as pathological prostatic growth.
hese observations may be particularly relevant for the rare
ndividuals who lack FUT1 function. These individuals
FIG. 6. Staining pattern and inhibitory activity of lectin UEA I. Th
or lectin UEA I (B) by staining adjacent sections of neonatal rat ven
ranching morphogenesis are significantly reduced relative to the c
o its own initial size) for organs grown in testosterone-containing se
lectin 1 (n 5 8), testosterone with lectin PNA 5 control lectin 2 (n 5
bars indicate the standard error for each data point.Copyright © 2001 by Academic Press. All rightere first identified because they have serum antibodies
gainst the A, B, and H blood group antigens, a condition
nown as the Bombay phenotype (Bhende et al., 1952). This
ondition is caused by inactivating mutations in the FUT1
ene (Kelly et al., 1994). Blood transfusion problems have
een the major medical focus with Bombay patients who
eject even type O blood due to their serum anti-H antibod-
es.
Aside from the presence of anti-H antibodies and the
bsence of H and derivative epitopes in Bombay patients, no
iological consequences of FUT1 loss have been reported.
n examination of the literature shows that at least 19
ombay pedigrees include at least 1 Bombay individual
ith children (Aloysia et al., 1961; Aust et al., 1962; Davey
t al., 1978; Fernandez-Mateos et al., 1998; Gandini et al.,
968; Gerard et al., 1982; Giles et al., 1963; Hakim et al.,
961; Parkin, 1956; Pretty et al., 1969; Rodier et al., 1974;
athe and Bhatia, 1976; Sin et al., 1976; Sringarm et al.,
977; Yunis et al., 1969). In these pedigrees, 10 male and 25
emale Bombay individuals with children are reported.
hese data indicate that loss of FUT1 is compatible with
ale fertility. However, the skewed ratio of fertile male vs.
ertile female Bombay individuals raises the possibility that
ale fertility is partially impaired by loss of FUT1. Taken
ogether with our data, which implicates FUT1 in prostatic
evelopment, these data suggest that Bombay males should
e further investigated for altered reproductive function. In
ddition, no information is available for the incidence of
ining pattern of mAb 2103 (A) was compared to the staining pattern
prostates. In the presence of lectin UEA I (F), prostatic growth and
l lectins (E). The average area increases (normalized for each organ
-free medium alone (n 5 8), testosterone with lectin DBA 5 control
or testosterone with lectin UEA I (n 5 12) are shown (C). The errore sta
tral
ontro
rum
8),s of reproduction in any form reserved.
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106 Marker et al.benign prostatic hyperplasia or prostatic adenocarcinoma
among Bombay patients. Our data implicating FUT1 as an
important mediator of prostatic growth and morphogenesis
suggest that the susceptibility of Bombay patients to these
pathologies should also be investigated.
CONCLUSION
This work defines a role for FUT1 in controlling epithe-
lial cell proliferation during prostatic development. This
work also shows that FUT1 has a novel and restricted
three-dimensional expression pattern in the developing
prostatic epithelial ductal network. The implication of
these findings is that FUT1 contributes to the spatial
control of epithelial cell proliferation during prostatic
branching morphogenesis. The novel three-dimensional ex-
pression pattern of FUT1 also suggests that FUT1 will
provide a useful marker for future studies of prostatic
development by defining a subset of the prostatic epithe-
lium not previously recognized as having unique molecular
properties. Expression of FUT1 in normal, benign prostatic
hyperplasia, and tumor-derived prostatic epithelial cells
FIG. 7. FUT1 mRNA expression in cultured prostates, prostatic
ell lines, and prostatic primary isolates. An ABI PRISM 7700
equence Detection System instrument was used to analyze FUT1
RNA expression levels. Expression was examined for prostates
ultured in the presence of physiologic levels of testosterone (T) or
ith an excess of the anti-androgen cyproterone acetate (CA).
xpression was calculated relative to cytokeratin19 to control for
ariability in amplification due to differences in starting mRNA
oncentration and changing epithelial–mesenchymal ratios during
he culture period (A). Expression was also examined for two cell
ines derived from normal adult rat prostate (NRP152 that is
ontumorigenic, NRP154 that is tumorigenic), one cell line derived
rom a rat prostate tumor (Dunning epithelium 5 DE), four primary
solates of human prostatic epithelium from patients with benign
rostatic hyperplasia (hPRE1, hPRE2, hPRE4, and hPRE5), one
uman cell line derived from benign prostatic hyperplasia (BPH1),
nd four human cell lines derived from metastatic prostate tumors
DU145, LNCAP, ND1, and PC3). For these experiments, expres-
ion was calculated relative to glyceraldehyde-3-phosphate-
ehydrogenase to control for variability in amplification due to
ifferences in starting mRNA concentration (B and C).Copyright © 2001 by Academic Press. All righturther raises the possibility that FUT1 may be important
n adults for normal prostate function as well as pathologi-
al prostatic growth. Finally, the fact that FUT1 can modu-
ate epithelial cell proliferation in the developing prostate
uggests that a fruitful area of future research will be to
xamine the potential roles of other carbohydrate modify-
ng enzymes during prostatic development.
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